uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Alsitek
Refused
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004398
ATC code
L01XE22
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of amyotrophic lateral sclerosis.
MeSH:
Amyotrophic Lateral Sclerosis
Group:
Antineoplastic agents
Active substances
Masitinib mesilate
Marketing Authorisation Holder
AB Science
MAH
Alsitek | uMedical